Materials Healthcare Sector

CRUSHMETRIC Group

Market Cap: UK£30.5m

A design and production company, integrates shape changing technology into catalogue of products in Hong Kong, Mainland China, and Singapore.

ZYUS Life Sciences

Market Cap: CA$56.6m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.

Earth Science Tech

Market Cap: US$41.2m

Focuses on health and wellness industry.

Grace Therapeutics

Market Cap: US$40.7m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Avalo Therapeutics

Market Cap: US$40.6m

A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.

Sharp Therapeutics

Market Cap: CA$55.4m

A preclinical-stage drug discovery company, developes therapeutics for genetic diseases.

Camp4 Therapeutics

Market Cap: US$40.3m

A clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.

Bioqual

Market Cap: US$40.2m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Pacific Edge

Market Cap: NZ$66.6m

A cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally.

Global Innovative Platforms

Market Cap: US$39.8m

Engages in the business of testing breath to detect and assist in the treatment of disease.

New Green Hemp

Market Cap: US$39.8m

New Green Hemp Inc. cultivates and sells hemp products.

Karyopharm Therapeutics

Market Cap: US$39.7m

A commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.

Vicarious Surgical

Market Cap: US$39.6m

Develops and sells single-port surgical robot in the United States.

Comjoyful International

Market Cap: US$39.1m

Operates and manages healthcare clubs in China.

Cryo-Cell International

Market Cap: US$39.0m

Engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use.

LianBio

Market Cap: US$38.9m

A biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries.

Spero Therapeutics

Market Cap: US$38.9m

A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.

Vitasora Health

Market Cap: AU$59.9m

An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States.

NurExone Biologic

Market Cap: CA$53.0m

Operates as a pharmaceutical technology company.

Annovis Bio

Market Cap: US$38.6m

A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.

Akari Therapeutics

Market Cap: US$38.6m

An oncology company, develops next-generation antibody-drug conjugates (ADC) and a novel discovery engine.

Institute of Biomedical Research

Market Cap: US$38.4m

Provides biomedical research and analytical services in Montenegro and internationally.

LTR Pharma

Market Cap: AU$58.8m

A biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.

Daxor

Market Cap: US$38.2m

A medical device company, provides blood volume measurement technology focused on blood volume testing.

Simply Solventless Concentrates

Market Cap: CA$51.9m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Estrella Immunopharma

Market Cap: US$37.6m

A clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.

Compumedics

Market Cap: AU$57.6m

Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe.

Iterum Therapeutics

Market Cap: US$37.3m

A pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States.

Helix BioPharma

Market Cap: CA$50.9m

Operates as an immune-oncology company in Canada.

Spectral AI

Market Cap: US$37.0m

An artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.

electroCore

Market Cap: US$36.9m

A bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.

Acrivon Therapeutics

Market Cap: US$36.7m

A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.

Provectus Biopharmaceuticals

Market Cap: US$36.7m

A clinical-stage biotechnology company, engages in developing immunotherapy medicines different diseases in the United States.

NeuroSense Therapeutics

Market Cap: US$36.5m

A clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally.

Futura Medical

Market Cap: UK£26.9m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

Renalytix

Market Cap: UK£26.5m

Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.